PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 129 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2020. The put-call ratio across all filers is 2.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,653 | +9297.6% | 4,431 | +12560.0% | 0.00% | – |
| Q2 2023 | $124 | +726.7% | 35 | -99.3% | 0.00% | – |
| Q1 2023 | $15 | -76.2% | 4,853 | -67.1% | 0.00% | -100.0% |
| Q4 2022 | $63 | -99.9% | 14,750 | -23.8% | 0.00% | +200.0% |
| Q3 2022 | $46,000 | -11.5% | 19,360 | +8.0% | 0.00% | 0.0% |
| Q2 2022 | $52,000 | +160.0% | 17,933 | +149.2% | 0.00% | – |
| Q1 2022 | $20,000 | -23.1% | 7,195 | -16.2% | 0.00% | – |
| Q4 2021 | $26,000 | -18.8% | 8,589 | +88.8% | 0.00% | -100.0% |
| Q3 2021 | $32,000 | -22.0% | 4,550 | +3.7% | 0.00% | 0.0% |
| Q2 2021 | $41,000 | -29.3% | 4,389 | -25.8% | 0.00% | 0.0% |
| Q1 2021 | $58,000 | -47.7% | 5,918 | -45.6% | 0.00% | -66.7% |
| Q4 2020 | $111,000 | +192.1% | 10,880 | +184.8% | 0.00% | – |
| Q3 2020 | $38,000 | -7.3% | 3,820 | -3.1% | 0.00% | -100.0% |
| Q2 2020 | $41,000 | -73.0% | 3,944 | -77.3% | 0.00% | -84.6% |
| Q4 2019 | $152,000 | +590.9% | 17,378 | +746.5% | 0.01% | +550.0% |
| Q3 2019 | $22,000 | -57.7% | 2,053 | +81.4% | 0.00% | -50.0% |
| Q3 2018 | $52,000 | +550.0% | 1,132 | +691.6% | 0.00% | – |
| Q2 2018 | $8,000 | -85.2% | 143 | -82.1% | 0.00% | -100.0% |
| Q1 2018 | $54,000 | +285.7% | 799 | +479.0% | 0.01% | +150.0% |
| Q4 2017 | $14,000 | -90.3% | 138 | -88.6% | 0.00% | -83.3% |
| Q3 2017 | $145,000 | +4733.3% | 1,211 | +1230.8% | 0.01% | – |
| Q1 2017 | $3,000 | -98.5% | 91 | -98.6% | 0.00% | -100.0% |
| Q4 2016 | $204,000 | +25.2% | 6,657 | +174.3% | 0.02% | +37.5% |
| Q3 2016 | $163,000 | +715.0% | 2,427 | +253.3% | 0.02% | +700.0% |
| Q2 2016 | $20,000 | -45.9% | 687 | -45.4% | 0.00% | -66.7% |
| Q1 2016 | $37,000 | -61.9% | 1,258 | +51.6% | 0.01% | -33.3% |
| Q2 2015 | $97,000 | -2.0% | 830 | +97.1% | 0.01% | -25.0% |
| Q1 2015 | $99,000 | +4.2% | 421 | -15.8% | 0.01% | +33.3% |
| Q4 2014 | $95,000 | -55.4% | 500 | -75.6% | 0.01% | -66.7% |
| Q1 2014 | $213,000 | +914.3% | 2,050 | +925.0% | 0.03% | +575.0% |
| Q4 2013 | $21,000 | -82.5% | 200 | -91.0% | 0.00% | -69.2% |
| Q3 2013 | $120,000 | +2300.0% | 2,234 | +2068.9% | 0.01% | – |
| Q2 2013 | $5,000 | – | 103 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $5,108,000 | 2.15% |
| Camber Capital Management LP | 4,235,000 | $12,070,000 | 0.52% |
| Kynam Capital Management, LP | 579,915 | $1,653,000 | 0.42% |
| GLOBEFLEX CAPITAL L P | 419,322 | $1,195,000 | 0.29% |
| Eversept Partners, LP | 1,435,077 | $4,089,969 | 0.29% |
| ARMISTICE CAPITAL, LLC | 1,500,000 | $4,275,000 | 0.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 506,066 | $1,442,000 | 0.07% |
| XTX Topco Ltd | 36,130 | $103,000 | 0.04% |
| State of Wyoming | 20,732 | $59,000 | 0.04% |
| Patriot Financial Group Insurance Agency, LLC | 55,500 | $158,000 | 0.03% |